Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Patient In-vivo Dosimetry (IVD) System industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
ATOMTEX
Mirion Technologies
Polimaster
Landauer
XZ LAB
Chiyoda Technol Corporation
Ludlum Measurements
Bertin Instruments
By Type:
Portable
Fixed
By Application:
Medical
Scientific Research
Others
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Patient In-vivo Dosimetry (IVD) System Market Overview 2018-2029
-
1.1 China Patient In-vivo Dosimetry (IVD) System Industry Development Overview
-
1.2 China Patient In-vivo Dosimetry (IVD) System Industry Development History
-
1.3 China Patient In-vivo Dosimetry (IVD) System Industry Market Size (2018-2029)
-
1.4 China Patient In-vivo Dosimetry (IVD) System Market Analysis by Type from Production Side
-
1.4.1 China Patient In-vivo Dosimetry (IVD) System Production Volume, Production Value and Growth Rate of Portable (2018-2029)
-
1.4.2 China Patient In-vivo Dosimetry (IVD) System Production Volume, Production Value and Growth Rate of Fixed (2018-2029)
-
1.5 China Patient In-vivo Dosimetry (IVD) System Market Analysis by Application from Consumption End
-
1.5.1 China Patient In-vivo Dosimetry (IVD) System Sales Volume, Sales Value and Growth Rate of Medical (2018-2029)
-
1.5.2 China Patient In-vivo Dosimetry (IVD) System Sales Volume, Sales Value and Growth Rate of Scientific Research (2018-2029)
-
1.5.3 China Patient In-vivo Dosimetry (IVD) System Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.6 China Patient In-vivo Dosimetry (IVD) System Market Analysis by Region
-
1.6.1 North China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate from 2018-2029
Chapter 2 China Patient In-vivo Dosimetry (IVD) System Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Patient In-vivo Dosimetry (IVD) System Market Status and Competition at home and abroad in 2023
-
2.2.2 China Patient In-vivo Dosimetry (IVD) System Market Status and Competition Analysis in 2023
-
2.2.3 China Patient In-vivo Dosimetry (IVD) System Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Patient In-vivo Dosimetry (IVD) System Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Patient In-vivo Dosimetry (IVD) System Industry Development
Chapter 3 Patient In-vivo Dosimetry (IVD) SystemIndustry Chain Analysis
-
3.1 Patient In-vivo Dosimetry (IVD) System Industry Chain
-
3.2 Patient In-vivo Dosimetry (IVD) System Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Patient In-vivo Dosimetry (IVD) System Market
-
3.3 Patient In-vivo Dosimetry (IVD) System Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Patient In-vivo Dosimetry (IVD) System Market
Chapter 4 China Patient In-vivo Dosimetry (IVD) System Market, by Type
-
4.1 China Patient In-vivo Dosimetry (IVD) System Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Patient In-vivo Dosimetry (IVD) System Total Production Volume and Growth Rate from Production Side
-
4.5 China Patient In-vivo Dosimetry (IVD) System Production Volume and Growth Rate, by Type
-
4.5.1 China Patient In-vivo Dosimetry (IVD) System Production Volume and Growth Rate of Portable
-
4.5.2 China Patient In-vivo Dosimetry (IVD) System Production Volume and Growth Rate of Fixed
Chapter 5 China Patient In-vivo Dosimetry (IVD) System Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Patient In-vivo Dosimetry (IVD) System Total Market Size and Growth Rate from Consumption End
-
5.5 China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate, by Application
-
5.5.1 China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate of Medical
-
5.5.2 China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate of Scientific Research
-
5.5.3 China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate of Others
Chapter 6 China Patient In-vivo Dosimetry (IVD) System Market, by Region
-
6.1 China Patient In-vivo Dosimetry (IVD) System Production Volume and Production Value, by Region
-
6.2 China Patient In-vivo Dosimetry (IVD) System Sales Volume and Sales Value, by Region
Chapter 7 North China Patient In-vivo Dosimetry (IVD) System Market Analysis
-
7.1 North China Patient In-vivo Dosimetry (IVD) System Market, by Type
-
7.2 North China Patient In-vivo Dosimetry (IVD) System Market, by Application
Chapter 8 Central China Patient In-vivo Dosimetry (IVD) System Market Analysis
-
8.1 Central China Patient In-vivo Dosimetry (IVD) System Market, by Type
-
8.2 Central China Patient In-vivo Dosimetry (IVD) System Market, by Application
Chapter 9 South China Patient In-vivo Dosimetry (IVD) System Market Analysis
-
9.1 South China Patient In-vivo Dosimetry (IVD) System Market, by Type
-
9.2 South China Patient In-vivo Dosimetry (IVD) System Market, by Application
Chapter 10 East China Patient In-vivo Dosimetry (IVD) System Market Analysis
-
10.1 East China Patient In-vivo Dosimetry (IVD) System Market, by Type
-
10.2 East China Patient In-vivo Dosimetry (IVD) System Market, by Application
Chapter 11 Northeast China Patient In-vivo Dosimetry (IVD) System Market Analysis
-
11.1 Northeast China Patient In-vivo Dosimetry (IVD) System Market, by Type
-
11.2 Northeast China Patient In-vivo Dosimetry (IVD) System Market, by Application
Chapter 12 Southwest China Patient In-vivo Dosimetry (IVD) System Market Analysis
-
12.1 Southwest China Patient In-vivo Dosimetry (IVD) System Market, by Type
-
12.2 Southwest China Patient In-vivo Dosimetry (IVD) System Market, by Application
Chapter 13 Northwest China Patient In-vivo Dosimetry (IVD) System Market Analysis
-
13.1 Northwest China Patient In-vivo Dosimetry (IVD) System Market, by Type
-
13.2 Northwest China Patient In-vivo Dosimetry (IVD) System Market, by Application
Chapter 14 Company Profiles
-
14.1 ATOMTEX
-
14.1.1 ATOMTEX Company Profile
-
14.1.2 ATOMTEX Patient In-vivo Dosimetry (IVD) System Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Mirion Technologies
-
14.2.1 Mirion Technologies Company Profile
-
14.2.2 Mirion Technologies Patient In-vivo Dosimetry (IVD) System Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Polimaster
-
14.3.1 Polimaster Company Profile
-
14.3.2 Polimaster Patient In-vivo Dosimetry (IVD) System Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Landauer
-
14.4.1 Landauer Company Profile
-
14.4.2 Landauer Patient In-vivo Dosimetry (IVD) System Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 XZ LAB
-
14.5.1 XZ LAB Company Profile
-
14.5.2 XZ LAB Patient In-vivo Dosimetry (IVD) System Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Chiyoda Technol Corporation
-
14.6.1 Chiyoda Technol Corporation Company Profile
-
14.6.2 Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Ludlum Measurements
-
14.7.1 Ludlum Measurements Company Profile
-
14.7.2 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Bertin Instruments
-
14.8.1 Bertin Instruments Company Profile
-
14.8.2 Bertin Instruments Patient In-vivo Dosimetry (IVD) System Market Performance
-
14.8.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Patient In-vivo Dosimetry (IVD) System Industry Research Conclusions
-
15.2 Patient In-vivo Dosimetry (IVD) System Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Patient In-vivo Dosimetry (IVD) System Industry Market Size (2018-2029)
-
Figure China Patient In-vivo Dosimetry (IVD) System Production Volume, Production Value and Growth Rate of Portable (2018-2029)
-
Figure China Patient In-vivo Dosimetry (IVD) System Production Volume, Production Value and Growth Rate of Fixed (2018-2029)
-
Figure China Patient In-vivo Dosimetry (IVD) System Sales Volume, Sales Value and Growth Rate of Medical (2018-2029)
-
Figure China Patient In-vivo Dosimetry (IVD) System Sales Volume, Sales Value and Growth Rate of Scientific Research (2018-2029)
-
Figure China Patient In-vivo Dosimetry (IVD) System Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure North China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate from 2018-2029
-
Figure Central China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate from 2018-2029
-
Figure South China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate from 2018-2029
-
Figure East China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate from 2018-2029
-
Figure Patient In-vivo Dosimetry (IVD) System Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Patient In-vivo Dosimetry (IVD) System Market Share by Type in 2018
-
Figure China Patient In-vivo Dosimetry (IVD) System Market Share by Type in 2023
-
Figure China Patient In-vivo Dosimetry (IVD) System Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Patient In-vivo Dosimetry (IVD) System Production Volume and Growth Rate of Portable (2018-2023)
-
Figure China Patient In-vivo Dosimetry (IVD) System Production Volume and Growth Rate of Fixed (2018-2023)
-
Figure China Patient In-vivo Dosimetry (IVD) System Market Share by Application in 2018
-
Figure China Patient In-vivo Dosimetry (IVD) System Market Share by Application in 2023
-
Figure China Patient In-vivo Dosimetry (IVD) System Total Market Size and Growth Rate from Consumption End
-
Figure China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate of Medical (2018-2023)
-
Figure China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate of Scientific Research (2018-2023)
-
Figure China Patient In-vivo Dosimetry (IVD) System Market Size and Growth Rate of Others (2018-2023)
-
Table China Patient In-vivo Dosimetry (IVD) System Production Volume by Region (2018-2023)
-
Table China Patient In-vivo Dosimetry (IVD) System Production Volume Share by Region (2018-2023)
-
Figure China Patient In-vivo Dosimetry (IVD) System Production Volume Share by Region (2018-2023)
-
Table China Patient In-vivo Dosimetry (IVD) System Production Value by Region (2018-2023)
-
Table China Patient In-vivo Dosimetry (IVD) System Production Value Share by Region (2018-2023)
-
Figure China Patient In-vivo Dosimetry (IVD) System Production Value Share by Region (2018-2023)
-
Table China Patient In-vivo Dosimetry (IVD) System Sales Volume by Region (2018-2023)
-
Table China Patient In-vivo Dosimetry (IVD) System Sales Volume Share by Region (2018-2023)
-
Figure China Patient In-vivo Dosimetry (IVD) System Sales Volume Share by Region (2018-2023)
-
Table China Patient In-vivo Dosimetry (IVD) System Sales Value by Region (2018-2023)
-
Table China Patient In-vivo Dosimetry (IVD) System Sales Value Share by Region (2018-2023)
-
Figure China Patient In-vivo Dosimetry (IVD) System Sales Value Share by Region (2018-2023)
-
Table North China Patient In-vivo Dosimetry (IVD) System Production Volume by Type (2018-2023)
-
Table North China Patient In-vivo Dosimetry (IVD) System Production Volume Share by Type (2018-2023)
-
Figure North China Patient In-vivo Dosimetry (IVD) System Production Volume Share by Type (2018-2023)
-
Table North China Patient In-vivo Dosimetry (IVD) System Sales Volume by Application (2018-2023)
-
Table North China Patient In-vivo Dosimetry (IVD) System Sales Volume Share by Application (2018-2023)
-
Figure North China Patient In-vivo Dosimetry (IVD) System Sales Volume Share by Application (2018-2023)
-
Table Central China Patient In-vivo Dosimetry (IVD) System Production Volume by Type (2018-2023)
-
Table Central China Patient In-vivo Dosimetry (IVD) System Production Volume Share by Type (2018-2023)
-
Figure Central China Patient In-vivo Dosimetry (IVD) System Production Volume Share by Type (2018-2023)
-
Table Central China Patient In-vivo Dosimetry (IVD) System Sales Volume by Application (2018-2023)
-
Table Central China Patient In-vivo Dosimetry (IVD) System Sales Volume Share by Application (2018-2023)
-
Figure Central China Patient In-vivo Dosimetry (IVD) System Sales Volume Share by Application (2018-2023)
-
Table South China Patient In-vivo Dosimetry (IVD) System Production Volume by Type (2018-2023)
-
Table South China Patient In-vivo Dosimetry (IVD) System Production Volume Share by Type (2018-2023)
-
Figure South China Patient In-vivo Dosimetry (IVD) System Production Volume Share by Type (2018-2023)
-
Table South China Patient In-vivo Dosimetry (IVD) System Sales Volume by Application (2018-2023)
-
Table South China Patient In-vivo Dosimetry (IVD) System Sales Volume Share by Application (2018-2023)
-
Figure South China Patient In-vivo Dosimetry (IVD) System Sales Volume Share by Application (2018-2023)
-
Table East China Patient In-vivo Dosimetry (IVD) System Production Volume by Type (2018-2023)
-
Table East China Patient In-vivo Dosimetry (IVD) System Production Volume Share by Type (2018-2023)
-
Figure East China Patient In-vivo Dosimetry (IVD) System Production Volume Share by Type (2018-2023)
-
Table East China Patient In-vivo Dosimetry (IVD) System Sales Volume by Application (2018-2023)
-
Table East China Patient In-vivo Dosimetry (IVD) System Sales Volume Share by Application (2018-2023)
-
Figure East China Patient In-vivo Dosimetry (IVD) System Sales Volume Share by Application (2018-2023)
-
Table Northeast China Patient In-vivo Dosimetry (IVD) System Production Volume by Type (2018-2023)
-
Table Northeast China Patient In-vivo Dosimetry (IVD) System Production Volume Share by Type (2018-2023)
-
Figure Northeast China Patient In-vivo Dosimetry (IVD) System Production Volume Share by Type (2018-2023)
-
Table Northeast China Patient In-vivo Dosimetry (IVD) System Sales Volume by Application (2018-2023)
-
Table Northeast China Patient In-vivo Dosimetry (IVD) System Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Patient In-vivo Dosimetry (IVD) System Sales Volume Share by Application (2018-2023)
-
Table Southwest China Patient In-vivo Dosimetry (IVD) System Production Volume by Type (2018-2023)
-
Table Southwest China Patient In-vivo Dosimetry (IVD) System Production Volume Share by Type (2018-2023)
-
Figure Southwest China Patient In-vivo Dosimetry (IVD) System Production Volume Share by Type (2018-2023)
-
Table Southwest China Patient In-vivo Dosimetry (IVD) System Sales Volume by Application (2018-2023)
-
Table Southwest China Patient In-vivo Dosimetry (IVD) System Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Patient In-vivo Dosimetry (IVD) System Sales Volume Share by Application (2018-2023)
-
Table Northwest China Patient In-vivo Dosimetry (IVD) System Production Volume by Type (2018-2023)
-
Table Northwest China Patient In-vivo Dosimetry (IVD) System Production Volume Share by Type (2018-2023)
-
Figure Northwest China Patient In-vivo Dosimetry (IVD) System Production Volume Share by Type (2018-2023)
-
Table Northwest China Patient In-vivo Dosimetry (IVD) System Sales Volume by Application (2018-2023)
-
Table Northwest China Patient In-vivo Dosimetry (IVD) System Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Patient In-vivo Dosimetry (IVD) System Sales Volume Share by Application (2018-2023)
-
Table ATOMTEX Company Profile
-
Table ATOMTEX Patient In-vivo Dosimetry (IVD) System Revenue, Price and Gross (2018-2023)
-
Table Mirion Technologies Company Profile
-
Table Mirion Technologies Patient In-vivo Dosimetry (IVD) System Revenue, Price and Gross (2018-2023)
-
Table Polimaster Company Profile
-
Table Polimaster Patient In-vivo Dosimetry (IVD) System Revenue, Price and Gross (2018-2023)
-
Table Landauer Company Profile
-
Table Landauer Patient In-vivo Dosimetry (IVD) System Revenue, Price and Gross (2018-2023)
-
Table XZ LAB Company Profile
-
Table XZ LAB Patient In-vivo Dosimetry (IVD) System Revenue, Price and Gross (2018-2023)
-
Table Chiyoda Technol Corporation Company Profile
-
Table Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Revenue, Price and Gross (2018-2023)
-
Table Ludlum Measurements Company Profile
-
Table Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Revenue, Price and Gross (2018-2023)
-
Table Bertin Instruments Company Profile
-
Table Bertin Instruments Patient In-vivo Dosimetry (IVD) System Revenue, Price and Gross (2018-2023)
-
